Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Innovative Pharmaceutical Biotech ( (HK:0399) ) has provided an update.
Innovative Pharmaceutical Biotech Limited announced a clarification regarding a clerical error in their previous announcement about the placing of new shares under a general mandate. The company clarified that the general mandate, which expired at the conclusion of their annual general meeting, will not be fully utilized upon the allotment and issue of all the placing shares. This announcement is intended to supplement the previous announcement and ensure accurate information is communicated to stakeholders.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited operates in the pharmaceutical and biotechnology industry, focusing on the development and commercialization of innovative medical products and technologies.
Average Trading Volume: 21,948,490
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.06B
See more insights into 0399 stock on TipRanks’ Stock Analysis page.